Butyl 3-O-caffeoylquinate



Compound IDCDAMM01235
Common nameButyl 3-O-caffeoylquinate
IUPAC namebutyl 3-[3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]-1,4,5-trihydroxycyclohexane-1-carboxylate
Molecular formulaC20H26O9

Experimental data

Retention time12.14
Adduct[M+H]+
Actual mz411.166
Theoretical mz411.165
Error1.03
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.805

Identifiers and class information

Inchi keyVNLREARKISTOAD-ALCCZGGFNA-N
SmilesO=C(OC1CC(O)(C(=O)OCCCC)CC(O)C1O)C=CC2=CC=C(O)C(O)=C2
SuperclassOrganic oxygen compounds
ClassOrganooxygen compounds

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)13
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)410.42
Computed dipole moment(dipole)7.791
Total solvent accessible surface area (SASA)721.381
Hydrophobic component of SASA (FOSA)299.915
Hydrophilic component of SASA (FISA)274.214
Pie component of the SASA (PISA)147.252
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1290.03
Number of hydrogen bond donors (donorHB)5
Number of hydrogen bond acceptors (accptHB)9.65
Free energy of solvation of dipole (dip^2/V)0.0470492
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0299122
Globularity descriptor (glob)0.794451
Predicted polarizability in cubic angstroms (QPpolrz)38.532
Predicted hexadecane/gas partition coefficient (QPlogPC16)14.369
Predicted octanol/gas partition coefficient (QPlogPoct)25.97
Predicted water/gas partition coefficient (QPlogPw)18.283
Predicted octanol/water partition coefficient (QPlogPo/w)1.114
Predicted aqueous solubility (QPlogS)-3.7
Conformation-independent predicted aqueous solubility (CIQPlogS)-3.903
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.56
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)24.861
Predicted brain/blood partition coefficient (QPlogBB)-3.117
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)9.122
Predicted skin permeability, log Kp (QPlogKp)-4.806
PM3 calculated ionization potential (IP(ev))9.169
PM3 calculated electron affinity (EA(eV))1.098
Number of likely metabolic reactions (#metab)5
Prediction of binding to human serum albumin (QPlogKhsa)-0.397
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)58.443
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)168.947
Number of nitrogen and oxygen atoms (#NandO)9
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P02766TTRTransthyretinT86462SEA
P05067APPBeta amyloid A4 proteinT87024SEA
P43166CA7Carbonic anhydrase VIIT37541SEA
P23280CA6Carbonic anhydrase VIT06569SEA
Q9ULX7CA14Carbonic anhydrase XIVT31992SEA
P11388TOP2ADNA topoisomerase II alphaT17048SEA
P10636MAPTMicrotubule-associated protein tauT45593SEA
Q04760GLO1Glyoxalase IT88285SEA
Q16236NFE2L2Nuclear factor erythroid 2-related factor 2T88505SEA
O43826SLC37A4Glucose-6-phosphate translocaseT47306SEA
Q15466NR0B2Nuclear receptor subfamily 0 group B member 2T89859SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T86462DI0026Amyloidosis[ICD-11: 5D00]P02766TTR
T87024DI0025Alzheimer disease[ICD-11: 8A20]P05067APP
T87024DI0122Diagnostic imaging[ICD-11: N.A.]P05067APP
T06569DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P23280CA6
T06569DI0372Seborrhoeic dermatitis[ICD-11: EA81]P23280CA6
T31992DI0046Bacterial infection[ICD-11: 1A00-1C4Z]Q9ULX7CA14
T31992DI0204Inborn metabolism deficiency[ICD-11: 5C50-5C59]Q9ULX7CA14
T17048DI0012Acute myeloid leukaemia[ICD-11: 2A60]P11388TOP2A
T17048DI0225Kaposi sarcoma[ICD-11: 2B57]P11388TOP2A
T17048DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P11388TOP2A
T45593DI0012Acute myeloid leukaemia[ICD-11: 2A60]P10636MAPT
T45593DI0025Alzheimer disease[ICD-11: 8A20]P10636MAPT
T45593DI0265Mild neurocognitive disorder[ICD-11: 6D71]P10636MAPT
T88285DI0210Influenza[ICD-11: 1E30-1E32]Q04760GLO1
T88505DI0038Ataxic disorder[ICD-11: 8A03]Q16236NFE2L2

Copyright © 2025